Skip to main content
SpringerLink
Log in

Proteolytic enzyme activities of macrophages and lymphocytes in neurological diseases

  • Short Communications
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

Studies showed a significant decrease in the macrophage neutral protease and lymphocyte acid protease activities in patients with multiple sclerosis in remission, a significantly decreased neutral protease activity in macrophages in patients with myasthenia gravis and a significantly decreased acid protease activity in macrophages and lymphocytes in patients with polymyositis. No remarkable abnormalities were found in patients with myotonic dystrophy. These results suggest that multiple sclerosis, myasthenia gravis and polymyositis have an abnormality in immunological function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Goto I, Shinno N, Kuroiwa Y (1983) Proteolytic enzyme activities in mononuclear cells and granulocytes of patients with various neurological disorders. J Neurol Sci 59:323–329

    Google Scholar 

  2. Kumagai K, Itoh K, Hinuma S, Tada M (1979) Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation. J Immunol Methods 29:17–25

    Google Scholar 

  3. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  4. McAdoo MH, Dannenberg AM Jr, Hayes CJ, James SP, Sanner JH (1973) Inhibition of the cathepsin D-type proteinase of macrophages by pepstatin, a specific pepsin inhibitor, and other substances. Infect Immunity 7:655–665

    Google Scholar 

  5. Paty DW, Kastrukoff L, Morgan N, Hiob L (1983) Suppressor Tlymphocytes in multiple sclerosis: analysis of patients with acute relapsing and chronic progressive disease. Ann Neurol 14:445–449

    Google Scholar 

  6. Rice GPA, Finney D, Braheny SL, Knobler RL, Sipe JC, Oldstone MBA (1984) Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT 4, OKT 5, and OKT 8. J Neuroimmunol 6:75–84

    Google Scholar 

  7. Serra S, Grynbaum A, Lajtha A, Marks N (1972) Peptide hydrolases in spinal cord and brain of the rabbit. Brain Res 44:579–592

    Google Scholar 

  8. Weissmann G, Zurier RB, Spieler PJ, Goldstein IM (1971) Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles. J Exp Med 134:149s-165s

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Neurological Institute, Faculty of Medicine, Kyushu University, 60, 3-1-1 Maidashi, Higashi-ku, 812, Fukuoka, Japan

    I. Goto, N. Shinno & Y. Kuroiwa

Authors
  1. I. Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Shinno
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y. Kuroiwa
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goto, I., Shinno, N. & Kuroiwa, Y. Proteolytic enzyme activities of macrophages and lymphocytes in neurological diseases. J Neurol 233, 373–375 (1986). https://doi.org/10.1007/BF00313926

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00313926

Key words

Search

Navigation